IDO1 and Cirrhosis: In the present study, we investigated the role of IDO1 in a clinical trial and in a carbon tetrachloride (CCl4)-induced hepatic fibrosis mouse model to obtain preclinical data for the treatment and/or chemoprevention of liver fibrosis (and even cirrhosis) by modulating IDO1 expression.